Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario E Lacouture

Showing results (1-10 of 257) with videos related to

Pageof 26
Sort By:
Cancer Nursing|August 19, 2007
Insights into the pathophysiology and management of dermatologic toxicities to EGFR-targeted therapies in colorectal cancerMario E Lacouture
Dermatologic Therapy|September 14, 2011
Cutaneous and mucosal reactions to oncologic therapyMario E Lacouture
Journal of the Advanced Practitioner in Oncology|November 21, 2017
Management of Dermatologic Toxicities Associated With Targeted TherapyMario E Lacouture
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Management of dermatologic toxicitiesMario E Lacouture
Nature Reviews. Cancer|September 23, 2006
Mechanisms of cutaneous toxicities to EGFR inhibitorsMario E Lacouture
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Skin care for cancer patientsMario E Lacouture
Oncology (Williston Park, N.Y.)|March 28, 2009
The growing importance of skin toxicity in EGFR inhibitor therapyMario E Lacouture
Science Translational Medicine|August 23, 2013
Skinflammation and drug toxicity--a delicate balanceMario E Lacouture, Ulrich Rodeck
The Oncologist|October 22, 2011
Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancerPatricia Gomez, Mario E Lacouture
Breast Cancer Research and Treatment|September 14, 2014
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabineGeorge Dranitsaris, Mario E Lacouture
Pageof 26

Showing results (1-10 of 257) with videos related to

Sort By:
Pageof 26
Cancer Nursing|August 19, 2007
Insights into the pathophysiology and management of dermatologic toxicities to EGFR-targeted therapies in colorectal cancerMario E Lacouture
Dermatologic Therapy|September 14, 2011
Cutaneous and mucosal reactions to oncologic therapyMario E Lacouture
Journal of the Advanced Practitioner in Oncology|November 21, 2017
Management of Dermatologic Toxicities Associated With Targeted TherapyMario E Lacouture
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Management of dermatologic toxicitiesMario E Lacouture
Nature Reviews. Cancer|September 23, 2006
Mechanisms of cutaneous toxicities to EGFR inhibitorsMario E Lacouture
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Skin care for cancer patientsMario E Lacouture
Oncology (Williston Park, N.Y.)|March 28, 2009
The growing importance of skin toxicity in EGFR inhibitor therapyMario E Lacouture
Science Translational Medicine|August 23, 2013
Skinflammation and drug toxicity--a delicate balanceMario E Lacouture, Ulrich Rodeck
The Oncologist|October 22, 2011
Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancerPatricia Gomez, Mario E Lacouture
Breast Cancer Research and Treatment|September 14, 2014
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabineGeorge Dranitsaris, Mario E Lacouture
Pageof 26